Premium Information is available for this item - Upgrade for $1 a day
6505-00-258-6994
Usp Quinidine Sulfate Capsules
6505002586994 002586994 QUINIDINESULFATE 517-0886-10
INC: 31176 Quinidine Sulfate Capsules
November 2023
8

Marketplace 6505-00-258-6994
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-258-6994 3+ Documents (More...)
/fsg-65/fsc-6505/us 6505-00-258-6994 Sulfate Capsules 6505002586994 Stock Numbers Related Usp Quinidine
Usp Quinidine Sulfate Capsules 6505002586994 Stock Numbers Related to 6505-00-258-6994 https https
Usp Quinidine Sulfate Capsules 6505002586994 /fsg-65/fsc-6505/us 6505-00-564- 6505002586994 https
Capsules 6505010519283 Capsules 6505005647320 CIN-QUIN Usp Quinidine Sulfate Sulfate Capsules 6505002586994
Usp Quinidine Sulfate Capsules 6505002586994 Usp Quinidine Sulfate Capsules 6505002586994 NATO
Quinidine Sulfate Capsules 6505005647320 Restrictions 6505-00-564-7320 DEMIL: A | DEMILI https 6505002586994
Restrictions 6505-00-258-6994
6505-00-258-6994 is a Usp Quinidine Sulfate Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-00-258-6994
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-258-6994
- Part Number
- Manufacturer
- Status
- 517-0886-10
- Manufacturer
- 32288 - Luitpold Pharmaceuticals Inc (Obsolete)
- Primary Buy
- Primary Buy
- QUINIDINESULFATE
- 32288 - Luitpold Pharmaceuticals Inc (Obsolete)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-00-258-6994
- Characteristic
- Specifications
- Capsule Type [AKJC]
- Specifications
- Any Acceptable
- Capsule Content Form [CQLS]
- Pellet
- Active Medicament Medicinal Strength [AKJA]
- 200.000 Milligrams Quinidine Sulfate Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Capsule Primary Container Content Quantity [CYLZ]
- 1000.000
Similar Supply Items to 6505-00-258-6994


















Freight Information 6505-00-258-6994
6505-00-258-6994 has freight characteristics.. 6505-00-258-6994 has a variance between NMFC and UFC when transported by rail and the description should be consulted.